We found that RASSF10 upregulated E-cadherin and ZO-1 and downregulated mesenchymal markers such as Vimentin and N-Cadherin, contributing to suppression of EMT and attenuation of HCC cell migration and invasion. The gene discussed is CDH2; the disease is hepatocellular carcinoma.